Respicardia, Inc.
An implantable neurostimulation device that automatically activates to treat central sleep apnea by modulating respiratory control
- Sector
- Medtech
- Headquarters
- Minnetonka, MN
- Founded
- 2006
- Latest Form D
- $20M, Dec 2017
- Total capital
- $89.4M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $89.4M
- 6 Form D · last Dec 2017
- 106 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 22
- 10 pending · first 2016
- Rank in peer group#100 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 6th filing$20M
- Private capital raisedForm D · SEC · 5th filing$5.1M
- Private capital raisedForm D · SEC · 4th filing$25.1M
- Private capital raisedForm D · SEC · 3rd filing$2M
- Private capital raisedForm D · SEC · 2nd filing$10M
- Private capital raisedForm D · SEC · 1st filing$27.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#100 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- B. Kristine JohnsonDirectorNamed in SEC Form D filings
- Bonnie LaboskyExecutive Officer, DirectorNamed in SEC Form D filings
- Edward AndrleDirectorNamed in SEC Form D filings
- Kirk Kristine NielsenDirectorNamed in SEC Form D filings
- Mike EllweinDirectorNamed in SEC Form D filings
- Scott WardDirectorNamed in SEC Form D filings
Show all 11 people
- Thomas Kristine WeldonDirectorNamed in SEC Form D filings
- Timothy HauchExecutive OfficerNamed in SEC Form D filings
- Wilf JaegerDirectorNamed in SEC Form D filings
- Wilfred JaegerDirectorNamed in SEC Form D filings
- William Kristine AbrahamDirectorNamed in SEC Form D filings
What it has protected
USPTO · 22 granted of 32- PendingSystems For Treating Disordered Breathing By Comparing Stimulated And Unstimulated BreathingUSPTOApplication 19315958
- GrantedSystem And Method To Modulate Phrenic Nerve To Prevent Sleep ApneaUSPTOUS 12,616,839
- PendingMedical Lead With Preformed BiasUSPTOApplication 19358871
Show all 32 patent records
- Systems For Treating Disordered Breathing By Comparing Stimulated And Unstimulated BreathingJun 11, 2026 · Application 19315958Pending
- System And Method To Modulate Phrenic Nerve To Prevent Sleep ApneaMay 5, 2026 · US 12,616,839Granted
- Medical Lead With Preformed BiasApr 16, 2026 · Application 19358871Pending
- Detecting And Treating Disordered BreathingFeb 24, 2026 · US 12,558,539Granted
- Medical Lead With Preformed BiasNov 11, 2025 · US 12,465,756Granted
- Systems For Treating Disordered Breathing By Comparing Stimulated And Unstimulated BreathingSep 23, 2025 · US 12,420,092Granted
- Monitoring System And User Interface For Monitoring Implantable Disordered Breathing Treatment SystemsSep 16, 2025 · US 12,414,709Granted
- Medical Lead And ImplantationJul 31, 2025 · Application 19026363Pending
- Transvascular Medical LeadJun 12, 2025 · Application 19023884Pending
- Detecting And Treating Disordered BreathingMar 13, 2025 · Application 18955418Pending
- Transvenous Phrenic Nerve Stimulation SystemMar 13, 2025 · Application 18957241Pending
- Transvascular Medical LeadFeb 25, 2025 · US 12,233,259Granted
- Medical Lead And ImplantationFeb 25, 2025 · US 12,233,258Granted
- Transvenous Phrenic Nerve Stimulation SystemDec 31, 2024 · US 12,179,014Granted
- Monitoring System And User Interface For Monitoring Implantable Disordered Breathing Treatment SystemsNov 7, 2024 · Application 18613723Pending
- Medical Lead With Preformed BiasJul 2, 2024 · US 12,023,487Granted
- Systems For Treating Disordered Breathing By Comparing Stimulated And Unstimulated BreathingJan 30, 2024 · US 11,883,659Granted
- Transvascular Medical LeadJan 9, 2024 · US 11,865,333Granted
- Transvascular Medical LeadJul 19, 2022 · US 11,389,648Granted
- Detecting And Treating Disordered BreathingJul 14, 2022 · Application 17709555Pending
- Detecting And Treating Disordered BreathingApr 19, 2022 · US 11,305,114Granted
- Medical Lead With Preformed BiasApr 19, 2022 · US 11,305,111Granted
- Respiratory RectificationJul 20, 2021 · US 11,065,443Granted
- Medical Lead And ImplantationNov 3, 2020 · US 10,821,280Granted
- Detecting And Treating Disordered BreathingMar 31, 2020 · US 10,603,491Granted
- System and Method to Modulate Phrenic Nerve to Prevent Sleep ApneaMar 19, 2020 · Application 16689740Pending
- Transvascular Medical LeadJan 28, 2020 · US 10,543,363Granted
- Medical Lead With Preformed BiasDec 17, 2019 · US 10,507,322Granted
- Device And Method For The Treatment Of Breathing Disorders And Cardiac DisordersMay 28, 2019 · US 10,300,270Granted
- Device And Method For The Treatment Of Breathing Disorders And Cardiac DisordersAug 29, 2017 · US 9,744,351Granted
- Muscle And Nerve StimulationMar 29, 2016 · US 9,295,846Granted
- Monitoring System And User Interface For Monitoring Implantable Disordered Breathing Treatment SystemsApplication 63148309Pending
Related companies, and why
- Nalu MedicalSimilar federal contract value in Medtech · null in contracts
- NURO INCSimilar federal contract value in Medtech · null in contracts
- INTERPACE BIOSCIENCES, INC.Similar federal contract value in Medtech · null in contracts
- SetPoint Medical CorpSimilar federal contract value in Medtech · null in contracts
- HOLOGIC INCSimilar federal contract value in Medtech · null in contracts
- VAIL SCIENTIFIC, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .